Wikidata

(Q64636112)

English

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

clinical trial

In more languages

Statements

title
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
United Kingdom
0 references
start time
31 July 2013
0 references
end time
1 July 2015
0 references
number of participants
891
0 references
minimum age
18 year
0 references
maximum age
100 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64636112&oldid=1857818407"